Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II Committee (Q36620597)
Jump to navigation
Jump to search
scientific article published on August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II Committee |
scientific article published on August 1999 |
Statements
1 reference
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II. CRC Phase I/II Committee (English)
1 reference
Twelves CJ
1 reference
Gardner C
1 reference
Flavin A
1 reference
Sludden J
1 reference
Dennis I
1 reference
de Bono J
1 reference
Beale P
1 reference
Vasey P
1 reference
Hutchison C
1 reference
Macham MA
1 reference
Rodriguez A
1 reference
Judson I
1 reference
Bleehen NM
1 reference
1 August 1999
1 reference
1 reference
1786-1791
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference